{"id":"https://openalex.org/W4379282969","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e16323","title":"Evaluation of bleeding risk between apixaban and rivaroxaban in patients with gastrointestinal cancer.","display_name":"Evaluation of bleeding risk between apixaban and rivaroxaban in patients with gastrointestinal cancer.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379282969","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e16323"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.e16323","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e16323","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16323","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16323","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16323","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092083654","display_name":"Parker Gundersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800194297","display_name":"Emory University Hospital Midtown","ror":"https://ror.org/02aknh966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I2800194297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Parker Gundersen","raw_affiliation_strings":["Emory University Hospital Midtown, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University Hospital Midtown, Atlanta, GA","institution_ids":["https://openalex.org/I2800194297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037284385","display_name":"Alexa J. Basilio","orcid":"https://orcid.org/0000-0003-3872-0508","observed_orcids":["https://orcid.org/0000-0003-3872-0508"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa Basilio","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043656268","display_name":"Amber Draper","orcid":"https://orcid.org/0000-0001-7172-205X","observed_orcids":["https://orcid.org/0000-0001-7172-205X"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber Draper","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083655","display_name":"Emily Tiao","orcid":"https://orcid.org/0000-0003-2325-6474","observed_orcids":["https://orcid.org/0000-0003-2325-6474"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Tiao","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006132935","display_name":"Marin Ibrahim Abousaud","orcid":"https://orcid.org/0000-0003-1829-0731","observed_orcids":["https://orcid.org/0000-0003-1829-0731"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marin Ibrahim Abousaud","raw_affiliation_strings":["Astellas, Northbrook, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas, Northbrook, IL","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051654669","display_name":"Olumide B. Gbolahan","orcid":"https://orcid.org/0000-0002-0598-4809","observed_orcids":["https://orcid.org/0000-0002-0598-4809","https://orcid.org/0000-0001-8477-4051"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olumide B. Gbolahan","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"e16323","last_page":"e16323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/gastrointestinal-cancer","display_name":"gastrointestinal cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9480000138282776},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.8119999766349792},{"id":"https://openalex.org/keywords/clinically-relevant-non-major-bleeding","display_name":"clinically relevant non-major bleeding","score":0.8399999737739563},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9660000205039978},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cancer-associated-thrombosis","display_name":"cancer-associated thrombosis","score":0.8379999995231628},{"id":"https://openalex.org/keywords/anticoagulation-safety","display_name":"anticoagulant safety","score":0.753000020980835},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.7450000047683716},{"id":"https://openalex.org/keywords/vte-recurrence","display_name":"VTE recurrence","score":0.7179999947547913},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.4519999921321869},{"id":"https://openalex.org/keywords/bleeding-risk-stratification","display_name":"bleeding risk stratification","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9708943367004395},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.937774658203125},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.9315293431282043},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.606406033039093},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5829457640647888},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.48040273785591125},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4273304343223572},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35442501306533813},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.22658401727676392},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.1459408700466156},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.05665886402130127}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.e16323","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e16323","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16323","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16323","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.e16323","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e16323","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16323","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16323","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4379282969.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310118196","https://openalex.org/W3194200408","https://openalex.org/W4414538149","https://openalex.org/W6887820865","https://openalex.org/W2914796199","https://openalex.org/W2906382048","https://openalex.org/W3104890556","https://openalex.org/W3008657804","https://openalex.org/W4401026155","https://openalex.org/W3082011734"],"abstract_inverted_index":{"e16323":[0],"Background:":[1],"Patients":[2],"with":[3,49,71,93,123,141,157,163,184,191,424,451],"cancer":[4,74,159,186,309,419],"are":[5,131],"at":[6,266],"a":[7,64,173,241],"higher":[8,65],"risk":[9,54,66,100,417],"for":[10,37,91,121,133,139,167,189,326,449],"developing":[11],"venous":[12],"thromboembolisms":[13],"(VTEs),":[14],"leading":[15],"to":[16,51,77,97,150,199,225,296,406,408,412],"further":[17],"complications.":[18],"The":[19,57,144,196,218,439],"National":[20],"Comprehensive":[21],"Cancer":[22,128],"Network":[23],"(NCCN)":[24],"guidelines":[25,114],"currently":[26],"recommend":[27,115],"using":[28,447],"low-molecular-weight":[29],"heparin":[30],"(LMWH)":[31],"or":[32,165,182,194,264,286],"direct":[33],"oral":[34],"anticoagulants":[35],"(DOACs)":[36],"the":[38,53,80,98,106,110,113,118,134,227,336,342,352,359,369,377,388,396,403,455],"treatment":[39,135,188,209],"of":[40,55,67,89,101,109,136,146,155,178,221,229,245,252,255,317,322,328,427,436,441,446],"VTEs":[41],"in":[42,69,105,203,243,335,341,348,351,358,365,368,376,384,387,395,418,454],"oncology":[43],"patients.":[44,420],"Other":[45],"trials":[46,111],"compare":[47],"DOACs":[48,130,410,448],"LMWH":[50,116],"determine":[52],"bleeding.":[56,293],"Select-D":[58],"trial":[59,82],"found":[60,83],"that":[61,84,260],"rivaroxaban":[62,166,343,360,378,397],"had":[63,86],"bleeding":[68,90,103,201,231,237,259,265,275,279,346,416],"patients":[70,92,122,140,156,179,204,324,350,367,375,386,394,450],"gastrointestinal":[72],"(GI)":[73],"as":[75,117,240,304],"compared":[76],"LMWH.":[78],"However,":[79],"Caravaggio":[81],"apixaban":[85,164,193,233,337,353,370,389],"no":[87],"increase":[88],"GI":[94,124,142,158,185,452],"cancer.":[95],"Due":[96],"inherent":[99],"major":[102,230,428],"shown":[104],"subgroup":[107],"analysis":[108],"above,":[112],"preferred":[119],"agent":[120],"cancers.":[125],"At":[126],"Winship":[127],"Institute,":[129],"used":[132],"cancer-associated":[137],"VTE":[138,190,208,288,381,437],"malignancies.":[143],"purpose":[145],"this":[147,222,329,442],"study":[148,171,197,223,405,443],"was":[149,224,238,422],"assess":[151],"real-world":[152],"safety":[153],"outcomes":[154,202,270,299],"who":[160,205],"were":[161,334],"treated":[162],"VTE.":[168],"Methods:":[169],"This":[170,401],"is":[172,402],"single-center,":[174],"retrospective":[175],"chart":[176],"review":[177,200],"18":[180,357],"years":[181],"older":[183],"receiving":[187],"either":[192],"rivaroxaban.":[195,235],"looks":[198],"started":[206],"their":[207,415],"from":[210,292],"January":[211],"1,":[212],"2017":[213],"\u2013":[214],"December":[215],"31,":[216],"2021.":[217],"primary":[219,308],"outcome":[220],"evaluate":[226,409],"rates":[228,426,435],"between":[232],"and":[234,290,313,315,339,356,373,392,414,430],"Major":[236,345],"defined":[239,277],"decrease":[242],"hemoglobin":[244],"\u2265":[246],"2g/dL":[247],"over":[248],"24":[249],"hours,":[250],"transfusion":[251],"\u22652":[253],"units":[254],"red":[256],"blood":[257],"cells,":[258],"requires":[261],"surgical":[262],"intervention,":[263],"critical":[267],"sites.":[268],"Secondary":[269],"included":[271,300],"clinically":[272],"relevant":[273],"non-major":[274],"(CRNMB)":[276],"by":[278],"compromising":[280],"hemodynamics,":[281],"hematemesis,":[282],"hemoptysis,":[283],"rectal":[284],"bleeding,":[285],"hematuria,":[287],"recurrence,":[289],"death":[291],"Data":[294],"collected":[295],"measure":[297],"these":[298],"patient":[301],"characteristics":[302],"such":[303],"renal":[305],"function,":[306],"weight,":[307],"site,":[310],"medication":[311],"dosing,":[312],"duration":[314],"indication":[316],"treatment.":[318],"Results:":[319],"A":[320],"total":[321],"300":[323],"qualified":[325],"inclusion":[327],"study.":[330],"Of":[331],"these,":[332],"89":[333],"group":[338,354,361,371,379,390,398],"211":[340],"group.":[344],"occurred":[347,364,383],"3":[349],"(3.4%)":[355],"(8.5%).":[362],"CRNMB":[363],"2":[366],"(2.2%)":[372],"16":[374],"(7.6%).":[380],"recurrence":[382],"4":[385],"(4.5%)":[391],"9":[393],"(4.3%).":[399],"Conclusions:":[400],"only":[404],"date":[407],"head":[411,413],"Apixaban":[421],"associated":[423],"lower":[425],"bleeds":[429],"CRNMB,":[431],"but":[432],"relatively":[433],"similar":[434],"recurrence.":[438],"results":[440],"warrant":[444],"consideration":[445],"cancers":[453],"upfront":[456],"setting.":[457]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-06-05T00:00:00"}